Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-03-02
1978-01-24
Miller, Edward A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 8, 424 12, G01N 3316, A61K 3900, A61K 4300, C07G 700
Patent
active
040704920
ABSTRACT:
New hapten compositions useful in preparing antigens which may be employed in eliciting antibodies useful in immunoassay, particularly radioimmunoassay for propranolol. Utilizing an enantiomer in formation of the hapten allows preparation of an antibody which is able to discriminate between enantiomers selectively.
REFERENCES:
patent: 3690834 (1972-09-01), Goldstein et al.
patent: 3704282 (1972-11-01), Spector
patent: 3852157 (1974-12-01), Rubenstein et al.
patent: 3878187 (1975-04-01), Schneider et al.
patent: 3975342 (1976-08-01), Gross
patent: 3988430 (1976-10-01), Dixon et al.
Gould George M.
Hoffmann-La Roche Inc.
Miller Edward A.
Nucker Christine M.
Welt Samuel L.
LandOfFree
Propranolol assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Propranolol assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Propranolol assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-489053